Pro-Pharma Q3 sales decline
Pro-Pharmaceuticals’ operating loss was $1.21m, compared to $1.25m for the comparable period in 2009. For the nine months ended 30 September 2010 Pro-Pharmaceuticals posted a net loss of
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.
Dalton supplies chemistry, analytical and formulation development services to the biotechnology and pharmaceutical industries in the areas of chemistry, medicinal chemistry and fine chemical manufacture. The company provides